---
title: Case 8
author: 'Mark Kriegsmann'
date: '2021-06-20'
slug: case-8
categories: ["cases"]
tags: ["thorax"]
subtitle: ''
summary: ''
authors: []
lastmod: '2021-06-20T08:55:50+02:00'
featured: no
image:
  caption: ''
  focal_point: ''
  preview_only: no
projects: []
weight: 993
---

<script src="{{< blogdown/postref >}}index_files/header-attrs/header-attrs.js"></script>


<div id="thoracic-tumor-in-a-50-year-old-man" class="section level1">
<h1>Thoracic tumor in a 50 year old man</h1>
<p><br></p>
<p><img src="/case8/he_1.5.png" alt="image1" />
<img src="/case8/he_10_1.png" alt="image2" />
<img src="/case8/he_10_2.png" alt="image3" /></p>
<details close>
<summary>
Immunohistochemistry
</summary>
<p><br>
beta-Catenin</p>
<img src="/case8/beta_10x.png" />
</details>
<details close>
<summary>
Whatâ€™s your diagnosis
</summary>
<p><br>
Desmoid Fibromatosis</p>
</details>
<details close>
<summary>
Notes
</summary>
<p><br></p>
<p><strong>Definion:</strong> <br>Locally aggressive fibroblastic / myofibroblastic tumor without metastatic potential <br>
<br>
<strong>Epidemiology and Localization:</strong> <br> Mean age: 36 - 42 years
<br><br>
<strong>Microscopy:</strong> <br> Bland spindle cells, typically with low mitotic activity. <br> Poorly defined. <br> Extravasated erythrocytes common. <br> May have myxoid, oedematous, or highly collagenous areas.
<br><br></p>
<p><strong>Immunohistochemistry and molecular pathology:</strong> <br> 90% CTNNB1 (exon 3 most common) and APC mutations .</p>
<p><strong>Therapy and Prognosis:</strong> <br> Recurrence in 20-30% <br> May undergo spontaneous regression. <br> May be managed conservatively, with surgery, radio- or chemotherapy. Surgery may induce growth, if not completely removed.</p>
<p><strong>References:</strong> <br><a href="https://www.pathologyoutlines.com/topic/softtissuefibromatosisdeep.html" class="uri">https://www.pathologyoutlines.com/topic/softtissuefibromatosisdeep.html</a></p>
</details>
</div>
